| Goodheart, Michael J; Ritchie, Justine M; Rose, Stephen L et al. (2005) The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer. Clin Cancer Res 11:3733-42 |
| Stone, Pamela J B; Goodheart, Michael J; Rose, Stephen L et al. (2003) The influence of microvessel density on ovarian carcinogenesis. Gynecol Oncol 90:566-71 |
| Rose, Stephen L; Robertson, Andrew D; Goodheart, Michael J et al. (2003) The impact of p53 protein core domain structural alteration on ovarian cancer survival. Clin Cancer Res 9:4139-44 |
| Rose, Stephen L; Goodheart, Michael J; DeYoung, Barry R et al. (2003) p21 expression predicts outcome in p53-null ovarian carcinoma. Clin Cancer Res 9:1028-32 |
| Hilton, Jeffrey L; Geisler, John P; Rathe, Jennifer A et al. (2002) Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst 94:1396-406 |
| Goodheart, Michael J; Vasef, Mohammad A; Sood, Anil K et al. (2002) Ovarian cancer p53 mutation is associated with tumor microvessel density. Gynecol Oncol 86:85-90 |
| Buller, R E; Shahin, M S; Holmes, R W et al. (2001) p53 Mutations and microsatellite instability in ovarian cancer: Yin and yang. Am J Obstet Gynecol 184:891-902; discussion 902-3 |
| Geisler, J P; Hatterman-Zogg, M A; Rathe, J A et al. (2001) Ovarian cancer BRCA1 mutation detection: Protein truncation test (PTT) outperforms single strand conformation polymorphism analysis (SSCP). Hum Mutat 18:337-44 |
